Delivery Order SPE2DR25D3402-SPE2DR26F1WQA
Award Date 12/17/25
Potential Completion Date 12/18/25
Potential Value $1.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $11,389.64 to AmerisourceBergen Drug Corp for the supply of Zepbound 15 mg/0.5 mL pens on November 24, 2025, with an ultimate completion date of November 25, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Zepbound is a semaglutide-based medication used for weight management in adults...
- The Defense Logistics Agency awarded a delivery order valued at $2,240.96 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 mL pen injections on November 4, 2025, with completion scheduled for November 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Zepbound is a semaglutide-based medication used for weight management, and...
- The Defense Logistics Agency awarded a delivery order valued at $3,159.90 to AmerisourceBergen Drug Corp for the supply of Zepbound 15 mg/0.5 ml pens on October 20, 2025. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of October 21, 2025. The contract will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Zepbound is a semaglutide-based weight management medication indicated for chronic weight...
- The Defense Logistics Agency awarded a $66,148.76 delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Zepbound 15 mg/0.5 mL pen injections. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 7, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Zepbound is a semaglutide-based medication indicated for weight management, reflecting the agency's procurement needs for...
- The Defense Logistics Agency awarded a delivery order valued at $25,850.22 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 mL pen injectors on December 5, 2025, with completion scheduled for December 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. Zepbound is a semaglutide-based medication used for weight management,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,458.10 on December 5, 2025, for the supply of Zepbound 12.5 mg/0.5 mL pen injections. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to the company's distribution facility in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a delivery order valued at $49,450.28 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injections on November 17, 2025, with an ultimate completion date of November 18, 2025. This firm fixed price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. Zepbound, a semaglutide-based medication for weight management, will support the...
- The Defense Logistics Agency awarded a delivery order valued at $19,055.28 to AmerisourceBergen Drug Corp for Zepbound 2.5 mg/0.5 mL pens on December 15, 2025, with an ultimate completion date of December 16, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Zepbound is a semaglutide-based injectable medication used for weight management,...
- The Defense Logistics Agency awarded a $46,152.35 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pens on October 28, 2025, with an ultimate completion date of October 29, 2025. Zepbound is a brand-name semaglutide product indicated for weight management in eligible patients. This delivery order was issued without set-aside designation, meaning it was competitively awarded through open competition. The place of performance is listed as...
- The Defense Logistics Agency awarded a $3,117.26 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 12.5 mg/0.5 mL pen injectors on November 18, 2025, with completion scheduled for November 19, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion and extending through December 2026. The contract was competitively awarded...